- TSX-V:UVC
Upper-Room Germicidal UV
The only Canadian-made, Health Canada-registered Upper-Room GUV in Canada. University of Leeds validated. 201–1,994 eACH, 99.7% pathogen kill, 166× the CDC recommendation.
Health Canada registered
Fan-integrated, Canadian-made, Health Canada-registered for continuous operation while rooms are in use.
201–1,994 eACH
University of Leeds validated, the best-performing upper-room UV device tested.
The Invisible Threat
When an infected person exhales, coughs, or sneezes, pathogen-laden aerosols spread throughout the room in minutes. Without intervention, everyone in the space is at risk.
Airborne pathogens can travel 6+ meters and remain infectious for hours. A single infected person can expose an entire room within minutes.
Masks, distancing, and ventilation depend on human behavior. Compliance drops over time. Infrastructure-based solutions work 24/7.
The UVC energy field continuously neutralizes pathogens in the upper room zone. Air is disinfected as it naturally circulates, protecting everyone below.
The Technology
A CDC-endorsed technology that uses germicidal ultraviolet light to continuously disinfect air in occupied spaces, without exposing people to harmful UV radiation.
Upper-room germicidal ultraviolet (GUV) systems use 254 nm UVC light to destroy airborne pathogens including bacteria, viruses, and fungi. The technology has been proven effective against tuberculosis, influenza, measles, and SARS-CoV-2.
Unlike portable air purifiers or HVAC filters, upper-room GUV provides continuous, real-time disinfection at the point of transmission. Pathogens are destroyed within seconds of becoming airborne, before they can reach another person.
The key innovation: UV fixtures are mounted near the ceiling and direct germicidal light into the upper-room zone, above head height. Natural air convection continuously cycles room air through this disinfection zone, while keeping people safely below.
SaniLume takes this further with active air circulation that dramatically increases the rate of air exchange through the UV zone, achieving performance 83–200× better than passive devices.
World-Leading Performance
University of Leeds testing validates SaniLume as the “best performing UV device tested to date.”
201–1,994
Equivalent Air Changes per Hour
CDC recommends 6–12 ACH for healthcare.
Equivalent Air Changes per Hour (eACH) measures how effectively a device removes pathogens from the air. It represents the pathogen reduction equivalent to completely replacing the room’s air that many times per hour.
The CDC recommends 6–12 air changes per hour for healthcare infection control. Typical upper-room GUV devices achieve 10–24 eACH. SaniLume achieves 201–1,994 eACH depending on room geometry and configuration — up to 166× the CDC recommendation and well above the performance of typical devices.
This isn’t a marginal improvement. This is a fundamentally different category of performance.
99.7%
Pathogen Elimination Rate
750
Square Feet Coverage
24
Day Hospital Payback
Only
Canadian Health Registered
Proven Science
Upper-room GUV is endorsed by the CDC, WHO, and ASHRAE. Published research demonstrates significant pathogen reduction.
Landmark study demonstrating upper-room GUV effectiveness in real-world healthcare settings with drug-resistant tuberculosis patients.
>70%
TB transmission reduction
Upper-room UVGI achieved rapid inactivation of SARS-CoV-2 virus at low irradiance levels in hospital isolation rooms.
90–99%
virus disinfection
CDC endorses upper-room GUV as a supplemental air cleaning technology for healthcare facilities and high-risk settings.
10–24
eACH typical devices
SaniLume vs. Devices Used in Published Research
10–24
eACH, typical GUV devices in landmark studies.
201–1,994
eACH, SaniLume.
83–200× more effective.
If those devices achieved 70–99% pathogen reduction, imagine what SaniLume delivers.
Active Technology
Unlike passive devices that hope air circulates through the UV zone, SaniLume actively moves air for guaranteed performance.
01
Integrated fans draw contaminated room air into the device at a controlled rate, not relying on passive convection.
02
Air passes through an intense 254 nm germicidal UV zone, destroying DNA/RNA of pathogens within seconds.
03
99.7% of bacteria, viruses, and fungi are eliminated, including antibiotic-resistant strains and airborne viruses.
04
Disinfected air is returned to the room, creating continuous circulation that protects occupants 24/7.
The signature performance
Not marginal improvement. A different category of air disinfection altogether, engineered, validated, Health Canada registered.
Up to 1,994
eACH
99.7%
Pathogen kill
Made in Canada
Health Canada-registered
Competitive Advantage
Head-to-head comparison with traditional upper-room GUV devices from major competitors, Signify, Atlantic UV, Xenex, Tru-D.
Traditional GUV
Signify · Atlantic UV · Xenex · Tru-D
SaniLume
Illumisoft Active GUV Technology
Industry-Leading Performance
The scale of the problem
Healthcare-associated infections kill more people than car accidents, diabetes, or influenza. The problem is global, the solution is proven, and the market is massive.
United States
Canada
Global
Market Opportunity
$82B
Global HAI Control Market by 2033
$3.2B+
Canadian Addressable Market (CHAIR)
24 Days
Average Hospital Payback Period
65–70%
SaniLume Gross Margins
CSA Z8000:24 requires GUV in healthcare ventilation systems.
CSA Z317.12:25 mandates infection control in healthcare facilities.
7 certified class action lawsuits against LTC facilities in Ontario.
SaniLume is Canadian-made and Health Canada-registered, with fan-integrated, occupied-space operation.
Canadian Market
$3.2B+ addressable market in Canada alone. CSA mandates and liability concerns are driving immediate adoption.
1,000+
Hospitals
100–1,000 units each
2,000+
LTC Facilities
Post-lawsuit mandates
15,500+
Schools
Public health priority
5,000+
Gov't Buildings
Federal / Provincial
The Business Case
SaniLume delivers rapid customer payback with the regulatory moats, Canadian manufacturing, and unmatched performance that create a sustainable competitive advantage.
Unit Economics
sq ft Coverage
750
Hospital Payback
24 Days
Annual eACH
201–1,994
Hospital ROI
CHAIR Projection
A $4,000 investment pays back in 24 days on HAI cost avoidance alone. Every year after is pure savings.
Applications
Any indoor environment where airborne pathogen transmission is a concern. Critical for healthcare, education, and high-traffic public spaces.
Hospitals Patient rooms, ORs, waiting areas, ICUs, emergency departments.
Long-Term Care Resident rooms, dining halls, common areas, staff stations.
Schools Classrooms, cafeterias, gymnasiums, administrative offices.
Commercial Open offices, conference rooms, lobbies, break rooms.
Government Courthouses, service centers, military facilities.
Hospitality Hotels, restaurants, convention centers, casinos.
Transportation Airports, train stations, bus terminals, waiting areas.
Fitness Gyms, yoga studios, locker rooms, swimming pool areas.
Ready to protect your indoor environment
